Patterns of co-occurrence of three single nucleotide polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene in kidney transplant recipients

European Journal of Clinical Investigation

Volumn 34, Issue 9, 2004, Pages 613-618

  Winkelmayer, Wolfgang C ^a   Sunder Plassmann, G ^b   Huber, A ^b   Fodinger M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

1298A > C; 677C > T; Genotypes; MTHFR 1793G > A; Renal transplants

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; CYTOSINE; GUANINE; THYMINE;

ADULT; ALLELE; ARTICLE; DOUBLE HOMOZYGOSITY; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETIC STABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 4944223701     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01394.x     Document Type: Article

References (20)

1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]. Nat Genet 1995;10:111-3.
2. Viel A, Dall'Agnese L, Simone F, Canzonieri V, Capozzi E, Visentin MC et al. Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 1997;75:1105-10.
3. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72.
4. van der Put NMJ, Gabreëls F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes TKAB et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
5. Födinger M, Hörl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000;13:20-33.
6. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R et al. The 1298A > C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-15.
7. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002;107:162-8.
8. Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 1999;10:891-900.
9. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-13.
10. Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A et al. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients. Am J Kidney Dis 2001;38:77-84.
11. 12 plasma concentrations in kidney graft recipients. J Am Soc Nephrol 2000;11:1918-25.
12. Winkelmayer WC, Eberle C, Sunder-Plassmann G, Födinger M. Effects of the glutamate carboxypepidase II (GCP2 1561C > T) and reduced folate carrier (RFC1 80G > A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 2003;63:2280-5.
13. Donnelly JG. The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with MboII restriction isotyping of the reported A1298C mutation. Mol Genet Metab 1999;68:511-2.
14. Kocsis I, Györffy B, Németh E, Vásárhelyi B. Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool. Kidney Int 2004;65:1956-8.
15. Isotalo PA, Donnelly JG. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000;5:59-66.
16. Volcik KA, Blanton SH, Northrup H. Examinations of methylenetetrahydrofolate reductase C677T and A1298C mutations- and in utero viability. Am J Hum Genet 2001;69:1150-3.
17. Ogino S, Wilson RB. Genotype and haplotype distributions of MTHFR 677C > T and 1298A > C single nucleotide polymorphisms: a meta-analysis. J Hum Genet 2003;48:1-7.
18. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms. An examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.
19. Goyette P, Pai A, Milos R. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mammalian Genome 1998;9:652-6.
20. Shan X, Wang L, Hoffmaster R, Kruger WD. Functional characterization of human methylenetetrahydrofolate reductase in Saccharomyces cerevisiae. J Biol Chem 1999;274:32613-8.